Harvard-trained ophthalmologists working alongside established, patent-holding scientists, engineers, and industry experts.

Management Team

Liane
Clamen, MD

Founder & CEO

Dr. Clamen is an ophthalmologist who earned her BA and MD at Harvard and completed her training at The Harvard Ophthalmology Residency Program at the Massachusetts Eye and Ear. She is the inventor of an Accommodating IOL, a punctal plug drug delivery system, and an anterior capsulotomy device.

Daniel Stanley, MS

Chief Operating Officer

Former Director of Intraocular Lens (IOL) Development at Alcon, Mr. Stanley has brought more than 30 IOL products from idea to market. With over 25 years of experience in the ophthalmology field,  Mr. Stanley brings a wealth of experience to Adaptilens. He had lead roles on an R&D team that grew a medical device product line from $10M to $1B a year.

Earlier in his career, Mr. Stanley was an Air Force Officer and rocket propulsion engineer.

Brett Thomes, PhD

Chief Information and Technology Officer

Former Senior Director of Process Development at Alcon, Dr. Thomes has extensive experience and knowledge in R&D and Manufacturing of IOLs. An award-winning process development leader, Dr. Thomes has over 20 years of experience in the ophthalmology field and has led a global R&D team during his time at Alcon. Dr. Thomes has a track record of achievements in delivering a broad range of Class I/II/III medical devices to the market.

Scientific Advisory Board

Sheila Borboli-Gerogiannis,
MD, FACS

Member, Scientific Advisory Board

Dr. Borboli-Gerogiannis is a Harvard-trained ophthalmologist who specializes in cataract surgery and corneal disease. She serves as Site Director of the Mass Eye and Ear Longwood and is a member of the Comprehensive Ophthalmology and Cataract Consultation Service at the Mass Eye and Ear.

An Assistant Professor of Ophthalmology at Harvard Medical School, Dr. Borboli-Gerogiannis is a well-respected medical educator whose primary focus is teaching resident physicians how to perform cataract surgery.

Cindy Chao,
MD, PhD

Member, Scientific Advisory Board

Dr. Chao earned her MD and PhD in molecular genetics from Harvard following her BS and MS from MIT. She completed her training at The Harvard Ophthalmology Residency Program at the Massachusetts Eye and Ear.

Dr. Chao was in clinical practice for 20 years, most recently at Ophthalmic Consultants of Boston. She specialized in cataract surgery and corneal conditions.

Thomas Clinch,
MD

Member, Scientific Advisory Board

Dr. Clinch is the founding partner of Eye Doctors of Washington and has practiced ophthalmology for more than 30 years. He has performed over 40,000 LASIK and 20,000 cataract procedures. He was educated at Cornell, Jefferson Medical College, and the Wills Eye Hospital.

Throughout his award-winning career, Dr. Clinch has provided innovative, state-of-the-art care. He has served as an investigator in more than 30 clinical studies pertaining to LASIK, PRK, and a variety of IOLs. Dr. Clinch has presented 100+ professional presentations and has authored over 40 scientific articles

Mathew L
Becker, PhD

Member, Scientific Advisory Board

Professor Becker teaches Chemistry, Mechanical Engineering, Materials Science, and Biomedical Engineering at Duke University. He has won many awards, including the 2019 Carl S. Marvel Award in Creative Polymer Chemistry from the American Chemical Society.

He is the author of 170+ papers, and holds 110+ issued or pending patents.

Thomas X
Neenan, PhD

Member, Scientific Advisory Board

A successful serial entrepreneur, Dr. Neenan is the Principal of Gray Door Partners LLC, a practice that develops university-based spinouts in science and biotech.

He is the author of 60+ publications and book chapters, and holds 45+ US and international patents.

Brian Levy,
OD, MSc

Member, Scientific Advisory Board

A proven leader in the field of Ophthalmology, Dr. Levy has extensive experience in Drug and Device Development. Dr. Levy was Chief Medical Officer of Bausch & Lomb and then Aerie Pharmaceuticals. He is currently Chief Executive Officer of OcuNexus Therapeutics, developing medications to treat chronic sight-threatening diseases.

He is a Clinical Professor in the Department of Ophthalmology at the University of Rochester’s School of Medicine and is the author of 50+ publications in peer-reviewed journals.

Business Advisors

William Shea, MBA

Partner

Mr. Shea has a 30-year career in the medical device industry. He was CEO of Medecom, The Clinipad Co., and New Dimensions in Medicine (NASDAQ: NDIM). He has served on numerous boards primarily where companies desired exits to larger strategic medical companies.

John Andres, JD

Partner

Mr. Andres is a patent attorney who has over 30 years of experience in the medical device industry in legal and business roles. He also served as VP and Co-General Counsel at US Surgical Corporation.

We're making:

An intraocular lens that imitates the young, healthy, human lens so that patients will have near, intermediate, and distance vision without eyeglasses or contact lenses.